Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-15T01:42:19.890Z Has data issue: false hasContentIssue false
  • English
  • Français

The Effects of Promazine (“Sparine”) in Chronic Schizophrenia

Published online by Cambridge University Press:  08 February 2018

R. Wallace Simpson  and
J. G. Jesson
R. Wallace Simpson
Affiliation:
Knowle Hospital, Fareham
J. G. Jesson
Affiliation:
Knowle Hospital, Fareham
Get access Rights & Permissions [Opens in a new window]

Extract

Promazine hydrochloride (“Sparine”) is a phenothiazine derivative which has recently been introduced to this country with claims to be a “tranquillizing” drug. It is closely related chemically to chlorpromazine but does not contain the chlorine atom which has been thought to cause the undesirable side effects of the promazine group. The structural formula of Sparine compares with that of chlorpromazine as follows:

Type
Original Articles
Information
Journal of Mental Science , Volume 104 , Issue 437 , October 1958 , pp. 1199 - 1202
Copyright
Copyright © Royal College of Psychiatrists, 1958 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Fazekas, J. F., Sullivan, P. D., and Shultz, J. D., Med. Ann. District Columbia, 1956, 25, 67.Google Scholar
Idem , Shultz, J. D., Sullivan, P. D., and Shea, J. G., J. Amer. Med. Ass., 1956, 160, 46.Google Scholar
Freed, H., Amer. Practit., 1955, 6, 706.Google Scholar
Mitchell, E. H., J. Amer. Med. Ass., 1956, 160, 44.CrossRefGoogle Scholar
Usdin, Gene L., J. Louisiana St. Med. Soc., 1956, 108, 251.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.